Aktsia Geron Corp (GERN) hind ja uudised

AvalehtGERN • NASDAQ

Geron Corp

1,24 $

Pärast sulgemist:

1,20 $

(3,23%)−0,040

Suletud: 16. apr, 16:30:00 GMT −4 · USD · NASDAQ · Välistus

AktsiaNoteeritud börsil: USAKoduriik: USA

Viimane sulgemishind

1,25 $

Tänane vahemik

1,17 $ - 1,25 $

Aasta vahemik

1,17 $ - 5,34 $

Turuväärtus

789,77 mln USD

Keskmine maht

14,77 mln

P/E suhe

Dividendimäär

Põhibörs

NASDAQ

Uudised

Yahoo Finance

7 tunni eest

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

KELOLAND.com

1 päeva eest

Shareholders That Lost Money on Geron Corporation (GERN) Should Contact Levi & Korsinsky About Pending Class Action - GERN

Morningstar

20 tunni eest

GERN Investors Have Opportunity to Lead Geron Corporation Securities Fraud Lawsuit

FOX4KC.com

10 tunni eest

GERN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

GlobeNewswire

6 tunni eest

GERN Investors Have the Opportunity to Lead the Geron Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

fox5sandiego.com

1 päeva eest

Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for Investors – Contact The Gross Law Firm

Teave

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia

Tegevjuht

John A Scarlett

Asutatud

1990

Peakontor

Menlo Park, California
Ameerika Ühendriigid

Veebisait

geron.com

Töötajate arv

229